DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,074 filers reported holding DANAHER CORPORATION in Q4 2022. The put-call ratio across all filers is 1.10 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $329,973 | +5.4% | 1,330 | +1.9% | 0.12% | +8.9% |
Q2 2023 | $313,200 | -1.0% | 1,305 | +4.0% | 0.11% | -6.7% |
Q1 2023 | $316,310 | +13.0% | 1,255 | +19.0% | 0.12% | +6.2% |
Q4 2022 | $280,018 | -20.0% | 1,055 | -22.1% | 0.11% | -22.6% |
Q3 2022 | $350,000 | +0.3% | 1,355 | -1.5% | 0.15% | +10.6% |
Q2 2022 | $349,000 | -12.8% | 1,375 | +0.7% | 0.13% | +7.3% |
Q1 2022 | $400,000 | +25.8% | 1,365 | +41.5% | 0.12% | +28.1% |
Q4 2021 | $318,000 | +8.2% | 965 | 0.0% | 0.10% | +2.1% |
Q3 2021 | $294,000 | +13.5% | 965 | 0.0% | 0.09% | +14.6% |
Q2 2021 | $259,000 | +19.4% | 965 | 0.0% | 0.08% | +6.5% |
Q1 2021 | $217,000 | +1.4% | 965 | 0.0% | 0.08% | -10.5% |
Q4 2020 | $214,000 | +2.9% | 965 | 0.0% | 0.09% | -7.5% |
Q3 2020 | $208,000 | -47.6% | 965 | -77.4% | 0.09% | -41.5% |
Q4 2017 | $397,000 | +8.5% | 4,275 | +0.1% | 0.16% | +7.4% |
Q3 2017 | $366,000 | +4.0% | 4,270 | +2.4% | 0.15% | -2.0% |
Q2 2017 | $352,000 | +1.1% | 4,170 | +2.5% | 0.15% | -4.4% |
Q1 2017 | $348,000 | +11.2% | 4,070 | +1.1% | 0.16% | +9.7% |
Q4 2016 | $313,000 | -0.6% | 4,025 | +0.1% | 0.14% | -5.3% |
Q3 2016 | $315,000 | – | 4,020 | – | 0.15% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
Third Point | 2,900,000 | $954,129,000 | 6.66% |
Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |